Glipizide
NDC 51655-180, Glipizide, tablet, from Northwind Health Company, LLC.
- Product NDC
- 51655-180
- Status
- Listed
- Labeler
- Northwind Health Company, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075795
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51655-180 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLIPIZIDE5 mg/1
Pharmacologic classes
Sulfonylurea Compounds [CS]; Sulfonylurea [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51655-180-25 | 51655018025 | 60 TABLET in 1 BOTTLE, PLASTIC (51655-180-25) |
| 51655-180-26 | 51655018026 | 90 TABLET in 1 BOTTLE, PLASTIC (51655-180-26) |
| 51655-180-52 | 51655018052 | 30 TABLET in 1 BOTTLE, PLASTIC (51655-180-52) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c16edad6-4271-6ff0-e053-2a95a90a0240
Use it
Look up 51655-180 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51655-180 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51655-180. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.